Literature DB >> 197126

Immune complexes in congenital and natal cytomegalovirus infections of man.

S Stagno, J E Volanakis, D W Reynolds, R Stroud, C A Alford.   

Abstract

The occurrence of circulating immune complexes was investigated in 31 patients with cytomegalovirus infection (29 infected in utero and 2 with natal infection) and 34 uninfected controls. Anti-complementary activity above 1:20 occurred in 34% (29/86) of the sera tested from the infected group in contrast to 7.5% (3/40) in the controls (P < 0.005). When assayed by means of a lymphoblastoid cell line (Raji cell test), the reactivity in these groups was 45 (39/86) and 2.7% (1/36), respectively (P < 0.001). Correlation of results between these two complement-dependent assays occurred in 75% of samples collected from the infected group. Frequency of reactivity was higher in severe intrauterine infection and during the 1st yr of life paralleling the patterns of viral excretion and humoral immune responses. Physicochemical characterization demonstrated that reactive substances in sera were acid-dissociable and, in one sample tested, contained 7S IgG antibodies with cytomegalovirus (CMV) specificity. Circulating immune complexes were heavier (18-22S) in sick, as opposed to subclinically CMV-infected patients, in whom intermediate size complexes (12-16S) were found. In three of four symptomatic patients whose demise was due to severe congenital infection, granular deposits of immunoglobulins and C3 were detected in a pattern typical of immune complexes along the glomerular basal membrane of the glomeruli. Whether or not circulation and deposition of heavier immune complexes contributed to the adverse clinical outcome is unresolved. Because of the high incidence of both congenital and natal CMV infections, definition of the pathogenetic potentials of both heavy and intermediate size immune complexes is required to design more effective therapeutic measures.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197126      PMCID: PMC372432          DOI: 10.1172/JCI108838

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  IgG antilymphocyte antibodies in SLE detected by 125I protein A.

Authors:  R C Williams; A D Bankhurst; J D Montaño
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

2.  Quantitative micro-complement fixation and its use in the study of antigenic structure by specific antigen-antibody inhibition.

Authors:  E WASSERMAN; L LEVINE
Journal:  J Immunol       Date:  1961-09       Impact factor: 5.422

3.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

Review 4.  Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin.

Authors:  M B Oldstone
Journal:  Prog Med Virol       Date:  1975

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation.

Authors:  M D Cooper; A R Lawton; D E Bockman
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

7.  Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections.

Authors:  S Stagno; D W Reynolds; A Tsiantos; D A Fuccillo; W Long; C A Alford
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

8.  Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections.

Authors:  S Stagno; D W Reynolds; C S Amos; A J Dahle; F P McCollister; I Mohindra; R Ermocilla; C A Alford
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

9.  Congenital cytomegalovirus infection.

Authors:  S Stagno; D W Reynolds; E S Huang; S D Thames; R J Smith; C A Alford
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

10.  Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes and autoimmunity during latent murine infection.

Authors:  L B Olding; D T Kingsbury; M B Oldstone
Journal:  J Gen Virol       Date:  1976-11       Impact factor: 3.891

View more
  20 in total

Review 1.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Use of isolated nuclei in the indirect fluorescent-antibody test for human cytomegalovirus infection: comparison with microneutralization, anticomplement, and conventional indirect fluorescent-antibody assays.

Authors:  S Stagno; D W Reynolds; R J Smith
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Interaction of cytomegalovirus immune complexes with host cells.

Authors:  B B Rundell; R F Betts
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

5.  Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay.

Authors:  S M Lemon; C D Brown; D S Brooks; T E Simms; W H Bancroft
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

6.  Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.

Authors:  J A Hardin; L C Walker; A C Steere; T C Trumble; K S Tung; R C Williams; S Ruddy; S E Malawista
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

7.  Effect of respiratory syncytial virus and virus-antibody complexes on the oxidative metabolism of human neutrophils.

Authors:  T N Kaul; H Faden; P L Ogra
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

8.  Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections.

Authors:  L Pereira; S Stagno; M Hoffman; J E Volanakis
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.

Authors:  W M Baldwin; A van Es; R M Valentijn; G W van Gemert; M R Daha; L A Vanes
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

10.  Circulating immune complexes in patients with acute measles and rubella virus infections.

Authors:  B Ziola; G Lund; O Meurman; A Salmi
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.